A peptide vaccine consisting of the bcr-abl b3a2 fusion oncoprotein, frequently expressed in chronic myelogenous leukemia (CML), with potential antineoplastic … [Read more...]
B
BCR-ABL fusion gene
A gene formed when pieces of chromosomes 9 and 22 break off and trade places. The ABL gene from chromosome 9 joins to the BCR gene on chromosome 22, to form the … [Read more...]
BCR-ABL fusion protein
A protein made from pieces of two genes that get joined together. It is found in most patients with chronic myelogenous leukemia (CML), and in some patients … [Read more...]
bcr-abl p210-b3a2 breakpoint-derived multipeptide vaccine
A multipeptide vaccine consisting of five peptides derived from the bcr-abl p210-b3a2 breakpoint fusion protein with potential antineoplastic activity. … [Read more...]
bcr-abl peptide vaccine
A multivalent antineoplastic vaccine comprised of the bcr-abl oncogene breakpoint fusion peptide that elicits a bcr-abl specific T-cell immune response. … [Read more...]
BCX-1777
A substance being studied in the treatment of some types of leukemia and lymphoma. It is a type of purine nucleoside phosphorylase (PNP) inhibitor. Also called … [Read more...]
BDC
A rare type of kidney cancer that grows and spreads quickly. It begins in the duct of Bellini in the kidney. Also called Bellini duct carcinoma. … [Read more...]
BEACOPP
An abbreviation for a chemotherapy combination used to treat advanced Hodgkin lymphoma. It includes the drugs bleomycin sulfate, etoposide phosphate, … [Read more...]
BEACOPP regimen
A chemotherapy regimen consisting of bleomycin, etoposide, doxorubicin hydrochloride (Adriamycin), cyclophosphamide, vincristine (Oncovin), procarbazine and … [Read more...]
Bead Block Compressible Microspheres
(Other name for: PVA microporous hydrospheres) … [Read more...]